Atai Life Sciences develops psychedelic-inspired therapies targeting mental health disorders through clinical trials.
Psychedelic compounds have near-zero downside when used medically with clinicians and can cure mental health issues; Atai is building the full suite of psychedelic medicines with first approvals expected early next year.